Cargando…
Factors Impacting Treatment Decision Making in Older Adults With Indolent Non-Hodgkin Lymphoma
Indolent non-Hodgkin lymphomas (NHL) are among the most common lymphomas and up to two-thirds of diagnoses are made in older adults (age≥65 years). Initial treatment options include cancer-directed therapy or active monitoring by the oncologist for disease progression. Despite the disparate nature o...
Autores principales: | Trevino, Kelly, Martin, Peter, Leonard, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680193/ http://dx.doi.org/10.1093/geroni/igab046.1985 |
Ejemplares similares
-
Higher Rates of Untreated Distress in Older Versus Younger Adults With Indolent Lymphoma
por: Trevino, Kelly, et al.
Publicado: (2020) -
Immunotherapy in indolent Non-Hodgkin's Lymphoma
por: Amhaz, Ghid, et al.
Publicado: (2022) -
Role of antibody-based therapy in indolent non-Hodgkin's lymphoma
por: Willard, Patrick, et al.
Publicado: (2021) -
The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma
por: Aldoss, Ibrahim T, et al.
Publicado: (2009) -
Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas
por: Leslie, Lori A.
Publicado: (2021)